# US 2026/0063553 A1 · Systems, devices and methods for cell capture and methods of manufacture thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0063553 A1
- Document ID: US20260063553A1
- Status: Published application
- Kind: A1
- Application number: 19/380,233
- Filed: 2025-11-05
- Published: 2026-03-05
- Earliest claimed: 2016-11-22
- Assignees: IsoPlexis Corporation
- Applicants: IsoPlexis Corporation
- Inventors: Peter TSIOMPLIKAS; Jerry SEDGEWICK; Jeffrey WHYNALL; Sean MACKAY; Colin NG; Patrick PACZKOWSKI; Sean MCCUSKER; Igor NIKONOROV; Alaina KAISER
- Web page: https://patentgrep.com/patent/US20260063553A1

## CPC

- G01N 21/6456: {Spatial resolved fluorescence measurements; Imaging}
- G01N 21/6458: {Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16)}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- C12M 1/34: Measuring or testing with condition measuring or sensing means, e.g. colony counters
- C12Q 1/25: involving enzymes not classifiable in groups C12Q1/26 {- C12Q1/66}
- G01N 33/487: of liquid biological material
- G01N 33/48728: {Investigating individual cells, e.g. by patch clamp, voltage clamp (investigating individual particles in general G01N15/10)}
- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- G01N 33/543: with an insoluble carrier for immobilising immunochemicals
- B01L 2200/0652: Sorting or classification of particles or molecules
- B01L 2300/04: Closures and closing means
- B01L 2300/0627: Sensor or part of a sensor is integrated
- B01L 2300/0819: Microarrays; Biochips
- B01L 2300/0851: Bottom walls
- B01L 2300/0864: comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
- B01L 2300/0877: Flow chambers
- B01L 2300/0893: having a very large number of wells, microfabricated wells
- B01L 2300/163: Biocompatibility
- B01L 2400/0481: squeezing of channels or chambers
- B01L 2400/049: vacuum
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Embodiments of the current disclosure are directed to systems, methods and apparatus for evaluating single cell secretion profiles. In some embodiments, the apparatus may be configured to analyze substances expressed by a biological cell and may include a first compressible substrate, and a second substrate configured for removable sealing attachment with the first substrate. In some embodiments, upon attachment of the second substrate with the first substrate, an assembly is formed such that the open side of the plurality of chambers are covered by the second substrate, and a portion of each of the plurality of capture areas are exposed in each of the chambers.

## Claims

### Claim 1

A method for analyzing one or more substances expressed by a cell, the method comprising:
(a) dispensing a sample containing cells into a cavity formed between a first substrate and a second substrate of an assembly, wherein
(i) the first substrate comprises a compressible material including a plurality of microchambers molded in the compressible material, each of the plurality of microchambers having an open side and configured to receive a cell, and
(ii) the second substrate comprises an array of capture areas, each capture area comprising a specific capture antibody;
(b) applying a compression force to the assembly such that the plurality of microchambers are reversibly sealed against the second substrate, the cells are trapped in the plurality of reversibly sealed microchambers, and a portion of each of the capture areas are exposed in each of the reversibly sealed microchambers;
(c) capturing one or more substances expressed by the cells in the plurality of reversibly sealed microchambers with the specific capture antibodies in the capture areas;
(d) removing the compression force from the assembly such that the cavity is formed between the first substrate and the second substrate;
(e) dispensing labeled secondary antibodies into the cavity to bind the one or more substances captured in the capture areas;
(f) washing the cavity to remove unbound labeled secondary antibodies; and
(g) detecting the one or more substances by imaging the capture areas to detect the labeled secondary antibodies bound to the capture areas.

### Claim 2 (depends on 1)

The method of claim 1, wherein the first substrate comprises silicone or polydimethylsiloxane.

### Claim 3 (depends on 1)

The method of claim 1, wherein the second substrate comprises glass.

### Claim 4 (depends on 1)

The method of claim 1, further comprising imaging the cells in the plurality of reversibly sealed microchambers.

### Claim 5 (depends on 4)

The method of claim 4, wherein the imaging comprises bright field microscopy.

### Claim 6 (depends on 4)

The method of claim 4, wherein the imaging comprises fluorescent microscopy.

### Claim 7 (depends on 4)

The method of claim 4, further comprising identifying reversibly sealed microchambers that contain only one cell.

### Claim 8 (depends on 1)

The method of claim 1, wherein at least some of the reversibly sealed microchambers contain only one cell.

### Claim 9 (depends on 1)

The method of claim 1, wherein the one or more substances comprise secreted proteins.

### Claim 10 (depends on 9)

The method of claim 9, wherein the secreted proteins comprise cytokines.

### Claim 11 (depends on 1)

The method of claim 1, wherein the cells are stained.

### Claim 12 (depends on 1)

The method of claim 1, wherein the first substrate comprises from 1,000 to 15,000 microchambers.

### Claim 13 (depends on 1)

The method of claim 1, wherein the microchambers have a depth of from 10 μm to 30 μm.

### Claim 14 (depends on 1)

The method of claim 1, wherein the microchambers have a width of from 10 μm to 30 μm.

### Claim 15 (depends on 1)

The method of claim 1, wherein the microchambers have a length of from 1,800 μm to 2,400 μm.

### Claim 16 (depends on 1)

The method of claim 1, wherein the second substrate comprises from 2 to 100 capture areas.

### Claim 17 (depends on 16)

The method of claim 16, wherein the substrate comprises from 20 to 50 capture areas.

### Claim 18 (depends on 1)

The method of claim 1, wherein the assembly further comprises a gasket disposed between the first substrate and the second substrate.

### Claim 19 (depends on 1)

The method of claim 1, wherein the capture areas are arranged on the second substrate in parallel lines.

### Claim 20 (depends on 1)

The method of claim 1, wherein imaging the capture areas to detect the labeled secondary antibodies comprises fluorescence microscopy.
